A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies
- 1 July 1992
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 167 (1) , 26-32
- https://doi.org/10.1016/s0002-9378(11)91619-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Need for a prospective treatment trialAmerican Journal of Obstetrics and Gynecology, 1990
- Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodyAmerican Journal of Obstetrics and Gynecology, 1989
- Lupus Anticoagulant, Thrombosis, and Fetal LossNew England Journal of Medicine, 1985
- Obstetric Complications Associated with the Lupus AnticoagulantNew England Journal of Medicine, 1985
- Fetal loss in systemic lupus: association with anticardiolipin antibodiesJournal of Obstetrics and Gynaecology, 1985
- LUPUS ANTICOAGULANT IN PREGNANCYThe Lancet, 1984
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANTThe Lancet, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)Acta Medica Scandinavica, 1975